NIH Clinical Center logo     America's Clinical Research Hospital File folder iconExplore the NIH
Clinical Center
Search the Studies - NIH Clinical Research Studies

Protocol Details

Magnetic Resonance Imaging at 1.5 and 3.0 Tesla

This study is currently recruiting participants.

Summary | Eligibility | Citations | Contacts

Summary

Number

87-CC-0091

Sponsoring Institute

National Institutes of Health Clinical Center (CC)

Recruitment Detail

Type: Participants currently recruited/enrolled
Gender: Male & Female
Min Age: N/A
Max Age: N/A

Referral Letter Required

No

Population Exclusion(s)

None

Special Instructions

Currently Not Provided

Keywords

Surface Coils;
T1-Weighted Images;
T2-Weighted Images;
Pulse Sequences;
Spin Echo;
Inversion Recovery;
Partial Saturation;
GRASS

Recruitment Keyword(s)

None

Condition(s)

Healthy

Investigational Drug(s)

None

Investigational Device(s)

None

Intervention(s)

None

Supporting Site

NIH Clinical Center

Magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) are diagnostic tests that allow researchers to look at different chemical properties of tissue. Magnetic resonance imaging and spectroscopy studies can be used to gather or evaluate information about various aspects of patient s bodies or to monitor changes in the biochemistry and physiology of patient s bodies.

Unlike other diagnostic techniques (CT scan and PET scan) MRI and MRS do not use ionizing radiation. Some studies have shown that MRI is more effective at distinguishing normal parts of the anatomy from abnormal anatomy, especially in the brain. MRI has become the diagnostic test of choice for evaluating patient with multiple sclerosis.

The purpose of this study is to evaluate normal volunteers and patients with a variety of diseases with magnetic resonance imaging. Researchers will attempt different magnetic resonance imaging methods and techniques as well as different levels of magnetic strength.

--Back to Top--

Eligibility

INCLUSION CRITERIA:

All patients undergoing MRI in the Clinical Center.

Patients must be able to provide informed consents.

EXCLUSION CRITERIA:

No contraindications to MRI.

Inability to understand consent form or consent process and the absence of a suitable guardian.

Refusal to Participate.


--Back to Top--

Citations:

Nuclear magnetic resonance imaging in oncology

Surface coil proton MR imaging at 2 TE

Cyclosporin-Anephroxity and acute cellular rejection in renal transplant recipients: correlation between radionuclide and histologic findings

--Back to Top--

Contacts:

Principal Investigator

Referral Contact

For more information:

John A. Butman, M.D.
National Institutes of Health Clinical Center (CC)
BG 10 RM 1C373X
10 CENTER DR
BETHESDA MD 20814
(301) 402-5827
jbutmana@cc.nih.gov

John A. Butman, M.D.
National Institutes of Health Clinical Center (CC)
BG 10 RM 1C373X
10 CENTER DR
BETHESDA MD 20814
(301) 402-5827
jbutmana@cc.nih.gov

Patient Recruitment and Public Liaison Office
Building 61
10 Cloister Court
Bethesda, Maryland 20892-4754
Toll Free: 1-800-411-1222
TTY: 301-594-9774 (local),1-866-411-1010 (toll free)
Fax: 301-480-9793

prpl@mail.cc.nih.gov

Clinical Trials Number:

NCT00001219

--Back to Top--

QUESTIONS?

Contact the Patient Recruitment and Public Liaison Office for:

  • Details on how to participate in a study
  • Details on how to refer a patient to a study

NIH Clinical Studies Information Request


Contact the Office of Communications for:

  • General information about the NIH Clinical Center

www.cc.nih.gov/contact.shtml


Contact the Department Clinical Research Informatics, (DCRI) for:

  • Technical questions about Adobe Acrobat and the PDF format
  • Technical questions about this web server

webmaster@cc.nih.gov